Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results


1.		Multihance Versus Magnevist in Breast MRI

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic				Active				18 and over				Pharmaceutical / Industry				MH 131 NCT00486473

Last Modified: 2/27/2008 First Published: 8/24/2006


2.		Phase II Study of Breast Tumor Viability Using Delayed Dynamic Contrast-Enhanced MRI After Radiofrequency Ablation in Women With Invasive Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Diagnostic, Treatment				Active				18 and over				NCI				UMN-2005LS006 UMN-0412M66271, NCT00373152

Last Modified: 1/9/2009 First Published: 4/1/2002


3.		Diagnostic Study of Contrast-Enhanced Magnetic Resonance Imaging and Correlative Molecular Studies in Women With Locally Advanced Breast Cancer Who Are Receiving Neoadjuvant Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Active				18 and over				NCI				CALGB-150007 NCT00033397

Last Modified: 12/22/2008 First Published: 8/1/2002


4.		Diagnostic Study of Contrast-Enhanced Breast Magnetic Resonance Imaging for Women With Stage III Breast Cancer Who Are Receiving Neoadjuvant Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Active				18 and over				NCI				ACRIN-6657 CALGB-150012, NCT00043017

Last Modified: 11/30/2006 First Published: 4/23/2003


5.		Diagnostic Study of Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging to Predict Likelihood of Progression and Potential Benefit of Treatment in Patients With Neurofibromatosis 1 and Plexiform Neurofibromas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Active				25 and under				Other				CHP-724 CHP-IRB-2001-8-2543, NCT00060008


6.		Dynamic Breast MRI in Assessing Locally Advanced Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic, Treatment				Active				Not specified				Other				237-2006 NCT00455273

Last Modified: 1/24/2008 First Published: 8/3/2007


7.		Study of Volume Imaging for Breast Assessment NT (VIBRANT-DE) and 3D Fast Spin-Echo Extended Echo-Train Acquisition (3DFSE-XETA) MRI Sequences for the Diagnosis of Breast Cancer in Women

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Active				Over 21				NCI				MSKCC-07091 07-091, NCT00514319


8.		Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic, Treatment				Active				18 to 80				Other				J06108 NA_00003943, NCT00539253


9.		Magnetic Resonance Imaging, Spectroscopic Imaging, and Contrast-Enhanced Imaging of the Prostate at 3 Tesla

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Active				21 and over				Other				06-035 NCT00588679

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute